📰 Joseph Stringer News
Joseph Stringer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Joseph Stringer. Real-time updates on events, politics, business and more.
April 10, 2024
Biotech stocks tend to outperform in the months leading up to an interest rate cut. But other factors are driving performance too.
April 9, 2024
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
January 5, 2024
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. PHAT, raising the price target to $26 from $23. "PHAT is our top pick…
January 5, 2024
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), 
November 14, 2023
Operator: Good afternoon. My name is Latif and I will be your conference facilitator.
August 22, 2023
BRASELTON - Robert "Bob" Stringer, 84, passed away on Thursday, August 17, 2023, at his home in Braselton.
August 21, 2023
BRASELTON - Robert "Bob" Stringer, 84, passed away on Thursday, August 17, 2023, at his home in Braselton.
August 10, 2023
Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript August 7, 2023 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00058 EPS, expectations were $0.56. Operator: Thank you for standing by, and welcome to Cara Therapeutics’ Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. […]
August 2, 2023
Operator: Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
August 2, 2023
Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill